Oncology News and Research

RSS
VELCADE based regimens are cost-effective for payers and patients, finds study

VELCADE based regimens are cost-effective for payers and patients, finds study

McKesson to introduce PROmanager-Rx system at the 44th Midyear Clinical Meeting and Exhibition

McKesson to introduce PROmanager-Rx system at the 44th Midyear Clinical Meeting and Exhibition

New analyses of data from Allos Therapeutics’ pivotal PROPEL trial of FOLOTYN reported

New analyses of data from Allos Therapeutics’ pivotal PROPEL trial of FOLOTYN reported

Alexion Pharmaceuticals announces positive data from AEGIS study of Soliris

Alexion Pharmaceuticals announces positive data from AEGIS study of Soliris

Amgen announces results from three studies on the safety and efficacy of Nplate

Amgen announces results from three studies on the safety and efficacy of Nplate

Updated safety data from Phase 2b 003-A1 study of carfilzomib announced

Updated safety data from Phase 2b 003-A1 study of carfilzomib announced

Study finds substantial variation in hydroxyurea utilization for sickle cell disease

Study finds substantial variation in hydroxyurea utilization for sickle cell disease

New findings may yield more effective therapies for infants with blood cancer

New findings may yield more effective therapies for infants with blood cancer

Positive final data from Phase 2 study of ISTODAX presented

Positive final data from Phase 2 study of ISTODAX presented

New treatment options for leukemia and myeloproliferative disorders introduced

New treatment options for leukemia and myeloproliferative disorders introduced

Health experts available to discuss health care reform

Health experts available to discuss health care reform

Genomic Health to present its Oncotype DX multi-gene expression test studies at the 32nd SABCS

Genomic Health to present its Oncotype DX multi-gene expression test studies at the 32nd SABCS

Partners HealthCare System's series 2009J fixed-rate revenue bonds rated 'AA'

Partners HealthCare System's series 2009J fixed-rate revenue bonds rated 'AA'

Vermillion files First Amended Plan of Reorganization and Disclosure Statement with the United States Bankruptcy Court

Vermillion files First Amended Plan of Reorganization and Disclosure Statement with the United States Bankruptcy Court

'Twist' gene plays a key role in the development of breast cancer

'Twist' gene plays a key role in the development of breast cancer

NCI awards $55.4 million, multiple-year contract to Fred Hutchinson Cancer Research Center

NCI awards $55.4 million, multiple-year contract to Fred Hutchinson Cancer Research Center

Aetna Medicare Advantage members now have access to MidState Medical Center and Windham Hospital

Aetna Medicare Advantage members now have access to MidState Medical Center and Windham Hospital

Hospira launches VisIV containers for intravenous medications and solutions

Hospira launches VisIV containers for intravenous medications and solutions

Amber Pharmacy receives ACHC accreditation

Amber Pharmacy receives ACHC accreditation

PLUS Diagnostics expands its specialty anatomic pathology services

PLUS Diagnostics expands its specialty anatomic pathology services

While we only use edited and approved content for Azthena answers, it may on occasions provide incorrect responses. Please confirm any data provided with the related suppliers or authors. We do not provide medical advice, if you search for medical information you must always consult a medical professional before acting on any information provided.

Your questions, but not your email details will be shared with OpenAI and retained for 30 days in accordance with their privacy principles.

Please do not ask questions that use sensitive or confidential information.

Read the full Terms & Conditions.